OSLO, 20 Mar 2025: CEPI is partnering with AstraZeneca, a global biopharmaceutical company, to advance a type of antibody that could significantly reduce costs compared to existing monoclonal antibodies and increase global access to antibody-driven disease prevention solutio......
View Details

Related News

• List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)

---

• DCA seized four medicines for misleading ‘Leucoderma’, ‘Tuberculosis’ and ‘Fever’ treatment claims (21-03-2025)

---

• Skin specialists flag widespread quackery in Kerala (21-03-2025)

---

• SHRC orders criminal proceedings against fake doctor (21-03-2025)

---

• Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)

---

• FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)

---

• Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India (20-03-2025)

---

• Impose safeguard duties on medical devices: AiMeD (20-03-2025)

---

• DCA seizes spurious ‘Montek-LC’ tablets in Secunderabad (20-03-2025)

---

• Tech Mahindra and NVIDIA Collaborate to Advance Drug Safety with Agentic AI-Powered Pharmacovigilance Solution (20-03-2025)

---